(Q42618250)

English

Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial

scientific article published on January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

sociodemography

1 reference

based on heuristic

inferred from title

Stephen R. Wisniewski

2

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Augustus John Rush

5

object named as

A John Rush

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Madhukar Trivedi

9

object named as

Madhukar H Trivedi

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

A Edward Friedman

1

object named as

Edward S Friedman

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Andrew Nierenberg

4

object named as

Andrew A Nierenberg

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

7

object named as

Sidney Zisook

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

6

object named as

Maurizio Fava

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

author name string

William Gilmer

3

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

G K Balasubramani

8

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Depression and Anxiety

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

612-621

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

21 January 2018

Cumulative illness rating scale

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

21 January 2018

Psychosocial Disability During the Long-term Course of Unipolar Major Depressive Disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Sertraline versus imipramine to prevent relapse in chronic depression.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of relapse in residual depression by cognitive therapy: a controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Report by the ACNP Task Force on response and remission in major depressive disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Research issues in the study of difficult-to-treat depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

The Psychiatric Diagnostic Screening Questionnaire: development, reliability and validity

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

The Inventory of Depressive Symptomatology (IDS): psychometric properties.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and demographic factors associated with DSM-IV melancholic depression.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Self-Rated Global Measure of the Frequency, Intensity, and Burden of Side Effects

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Web-based communications and management of a multi-center clinical trial: the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Suicide risk management for the sequenced treatment alternatives to relieve depression study: applied NIMH guidelines.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Socioeconomic status and health: what we know and what we don't

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Class - the ignored determinant of the nation's health

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Socioeconomic inequalities in depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of treatments for major depression in primary medical care practice: a post hoc analysis of outcomes for African American and white patients

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Treating minority patients with depression and anxiety: what does the evidence tell us?

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Sertraline treatment of co-occurring alcohol dependence and major depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Linking antisocial behavior, substance use, and personality: an integrative quantitative model of the adult externalizing spectrum

1 reference

https://api.crossref.org/works/10.1002%2FDA.20568

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DA.20568

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42618250&oldid=1962893801"